Securities Litigation

Securities Litigation

Paul, Weiss is widely recognized as having one of the nation’s preeminent securities litigation and regulatory practices. For two decades, our lawyers have guided global corporations and financial institutions through a series of “bet-the-company” securities-related crises, consistently reducing or eliminating their most damaging claims and negotiating favorable resolutions.

From the days of insider trading and corporate raiders in the 1980s, to the recent collapse of the subprime and auction-rate securities markets, Paul, Weiss has played a leading defensive role in nearly every high-profile securities matter of the modern era. In each instance, we have helped our clients respond to the fallout, mitigate crises and successfully resolve public and private litigations and government investigations.

We have experience handling virtually every kind of securities-related challenge, including:

  • Shareholder class actions
  • Suits by large institutional investors
  • Shareholder derivative suits
  • Complex parallel proceedings
  • Merger, acquisition and proxy contest-related actions
  • ERISA claims
  • Cases arising out of investment partnerships and private funds
  • Investment arbitrations
  • Internal investigations
  • Government investigations
  • Government enforcement actions
  • Securities opt-out claims

Our lawyers represent U.S. and non-U.S. clients in civil and criminal proceedings in state and federal courts across the United States, as well as in administrative proceedings and investigations by U.S. regulatory authorities and self-regulatory organizations. We help issuers successfully navigate the labyrinth of litigation that can arise from public offerings of equity and debt, as well as from earnings disclosures, restatements and other adverse developments. We are also frequently tapped by underwriters in individual shareholder or class actions claiming liability for misstatements and omissions in registration statements and prospectuses, as well as individual board members and executive officers targeted in securities-related suits. Our vast expertise in defending lawsuits arising under virtually every provision of the relevant federal statutes, state statutory provisions and common law has allowed us to help shape precedent in this area.

The collective wisdom of our team is formidable. The practice boasts a deep bench of experts, including many former federal prosecutors who have invaluable experience in dealing with U.S. Attorney offices, the U.S. Department of Justice and state prosecutors. Notably, our team includes the former deputy chief of the Fraud Section of the DOJ’s Criminal Division, two former chiefs of the Criminal Division of the New York U.S. Attorney’s Office, two former deputy directors of the SEC’s Enforcement Division, the former Deputy General Counsel of the U.S. Treasury Department, a former counsel of two SEC chairs and a former Vice Chancellor of the Delaware Court of Chancery. Many other lawyers have devoted their careers to the defense of securities litigations in state and federal court and before regulatory bodies.

In representing non-U.S. clients, we offer not only knowledge of the legal issues unique to foreign entities and individuals, but also a sure hand in leading them through the unfamiliar landscape of the U.S. legal and regulatory system. We have deep experience navigating increasingly frequent cross-border crisis situations for our clients, where U.S. securities litigation is often accompanied by other litigation, insolvency or regulatory matters abroad, and managing the complex interplay among them.

Securities Litigation

Our clients benefit from our deep experience at all stages of the litigation process, including motions to dismiss, class certification, summary judgment, settlements, trials and appeals, as well as before domestic and international investment arbitration bodies. We defend clients in lawsuits arising under federal and state securities laws, as well as litigating securities-related issues arising under other statutory schemes, including ERISA and the U.S. Bankruptcy Code.

Our practice is differentiated because not only do we have unparalleled subject matter expertise, but we try cases, including securities cases, and win them. Our team includes litigators who are widely recognized as some of the finest trial lawyers in the country. Clients and adversaries know that we are prepared to take cases to trial and that we know how to win, which gives us a tremendous advantage both in the courtroom and at the settlement table. In fact, we have successfully taken numerous multi-billion dollar cases to verdict in recent years, collectively reducing our clients’ liability by scores of billions of dollars. Because of our record of achievement, we are often pulled into litigation after a class has been certified and a matter is headed for trial.

At the outset of each new matter, we engage in comprehensive strategic planning with our clients to manage their risk and exposure and to tailor our strategy to the matter’s unique facts, drawing on our institutional knowledge of the securities laws and precedent. Because we leverage our past work so efficiently, we are a highly cost-effective choice of counsel.

Securities Regulatory Matters

Recent years have brought ever-heightened regulatory scrutiny and enforcement in the securities area. We have vast experience before all of the regulatory agencies and entities that clients are likely to face. Our lawyers frequently appear at the SEC; before the U.S. Congress, self-regulatory organizations and independent commissions; and in state Attorney General offices from New York to California, representing clients in civil investigations and administrative proceedings. Both because of our team’s experience working in government, and our frequent appearance before key regulators, we bring both credibility and expertise to our client’s toughest regulatory challenges. We have a proven track record, using creative strategies, of persuading regulators not to pursue actions against our clients where it is not warranted. Just as important, regulators know that when necessary, we also have the expertise to represent our clients at trial. And we are particularly adept at helping clients navigate inquiries from multiple regulators.  

Internal Investigations

Our clients also look to us to conduct sensitive internal investigations. We have handled investigations into issues from alleged accounting irregularities and deficiencies in internal controls, to tax reporting and related-party transactions, to suspicious trading activities and misappropriation of assets. These types of investigations often raise challenging questions of corporate governance, an area where we are acknowledged experts. We regularly represent boards of directors in advising them on how to exercise their duties in the context of securities-related and other issues. We also regularly offer proactive business counsel and comprehensive strategic advice on managing securities regulatory and litigation risk.

“A dominant securities litigation practice that attracts leading financial institutions, alongside multinational corporates from a breadth of industries.”

- Chambers USA 

Recognition

Benchmark Litigation: Securities Firm of the Year 

  • Ranked Band 1 in Securities Litigation by Chambers USA since 2005.
  • Law360: Securities Group of the Year (2014-2017, 2020)
  • Ranked Tier 1 by The Legal 500 US in Securities Litigation: Defense 

Recent Engagements

  • ADT Corporation, a leading securities systems company, in the successful defense of a securities regulatory probe, securities class action and shareholder derivative actions challenging the company’s billion-dollar stock buyback from a corporate activist that occurred just before ADT announced a disappointing quarter, leading to a share price decline. Paul, Weiss obtained the dismissal of the derivative actions and securities class action, establishing the precedent that companies have broad authority to buy back their shares; the SEC concluded its investigation without taking action.
  • Amazon.com, Inc. and various executives and employees in the dismissal of a class action filed by Amazon shareholders alleging that defendants made false and misleading statements or omissions regarding Amazon’s private-label business practices, including the use of third party seller data, and the capacity of Amazon’s fulfillment network.
  • American International Group (AIG) in the successful settlement of a securities class action and derivative lawsuits seeking over $20 billion in damages related to allegations of anticompetitive market division, accounting violations and stock price manipulation under a former AIG CEO.
  • Bank of America (BofA) in the successful settlement of a securities class action alleging that BofA and its directors and officers made material misstatements and omissions when seeking shareholder approval for the company’s merger with Merrill Lynch in 2008. The suit was settled for less than 10 cents on the dollar.
  • Citigroup in:
    • defeating two separate multibillion-dollar arbitral claims brought by the Abu Dhabi Investment Authority (ADIA) in connection with losses the sovereign wealth fund sustained in its $7.5 billion investment in Citigroup;
    • securing the dismissal of multiple multibillion-dollar ERISA “stock drop” actions, most recently in the dismissal, affirmed on appeal, of claims made by retirement plan participants alleging that the company should not have allowed them to invest in Citigroup stock from 2008 to 2009, when the value of their investments allegedly dropped by more than $1.5 billion;
    • numerous matters related to residential mortgage-backed securities arising out of the credit crisis, including federal and state regulatory investigations; securities litigation in federal and state courts across the country; breach of contract claims; and various out-of-court mediations. Of several dozen different investigations and lawsuits since 2010, almost all have been dismissed with prejudice or resolved consensually on favorable terms; and
    • arguably the most important regulatory appellate decision in the past decade, SEC v. Citigroup, which upheld the ability of corporations to resolve federal regulatory matters without having to admit liability.
  • Dennis J. “Chip” Wilson, founder of lululemon athletica in the dismissal of a securities class action and derivative litigation alleging the company had omitted to disclose deficiencies in the company’s quality control procedures, and that Mr. Wilson had motive to conceal the product issues from investors because he profited by selling lululemon stock during the relevant period.
  • Ericsson in securing the dismissal, affirmed on appeal, of a securities class action arising out of the company’s 2007 financial disclosures.
  • Goldman Sachs Group as co-lead counsel in a billion-dollar, long-running securities class action filed in the wake of a 2010 SEC action alleging that Goldman Sachs helped a client short a collateralized debt obligation that the bank was simultaneously selling to customers, ultimately losing those customers $1 billion. After securing an important U.S. Supreme Court decision, Paul Weiss won a major victory at the Second Circuit when the panel unanimously reversed certification of the investor class action and instructed the district court to decertify the class. The plaintiffs subsequently declined a last chance to appeal Goldman’s resounding appellate win and voluntarily dismissed their case, bringing a decade of hard-fought litigation to a close.
  • HCP, Inc., a REIT invested primarily in real estate serving the healthcare industry, in an ongoing putative securities class action and derivative litigation alleging that HCP and its current and/or former directors failed to make sufficient disclosures about the company’s financial condition and portfolio.
  • Imperial Sugar Company and its former executives in securing the dismissal of several derivative lawsuits and a federal securities class action alleging defendants made material misrepresentations about the company’s use of co-packers and its purchase of sugar from other refiners. Paul, Weiss also successfully represented Imperial Sugar’s board in connection with shareholder opposition to its merger with Louis Dreyfus Commodities.
  • iStar Financial Inc. in securing the dismissal of a putative class action and derivative complaint, affirmed on appeal, alleging the company and its directors improperly modified financial awards to its senior management, breached fiduciary duty and wasted corporate assets.
  • JPMorgan Chase & Co. in the litigation and settlement of a securities class action and several opt-out cases brought by investors in The Bear Stearns Companies Inc. who alleged that Bear Stearns’s public disclosures misrepresented the company’s financing, leverage, liquidity, capital, risk management and mortgage business prior to its near-collapse and subsequent acquisition by JPMorgan Chase in 2008.
  • Outside Directors of JPMorgan Chase & Co. in the dismissal of a shareholder derivative lawsuit alleging our clients breached their fiduciary duties in connection with the bank’s prior relationship with former client Jeffrey Epstein.
  • Kirkland Lake Gold, as well as its former CEO, in defeating class certification in a securities fraud class action arising from alleged misrepresentations about its strategy for future acquisitions of gold mining companies.
  • Kohlberg & Co., LLC and certain affiliates in securing the dismissal of a stockholder derivative action brought by a pension fund shareholder against home infusion services provider BioScrip, Inc., a company in which Kohlberg owned 26% of its shares, alleging that certain current and/or former directors and officers violated various federal and state laws in allegedly causing BioScrip to engage in a drug sales kickback scheme. Paul, Weiss also defeated an amended complaint made by the investor plaintiff, now on appeal.
  • MagnaChip Semiconductor Corporation and two current and former outside directors in securing a favorable resolution of a consolidated securities class action alleging that the company issued false and misleading statements, failed to disclose the inadequacy of its internal controls and inflated its financial results. Paul, Weiss negotiated a settlement of the securities litigation for an amount equal to 7.1% of maximum estimated damages and without any admission of fault or wrongdoing, and of a parallel SEC investigation of certain financial restatements.
  • Merck & Co.:
    • along with its former subsidiary Medco Health Solutions, Inc. and five of the company’s officers and directors in securing the dismissal with prejudice, affirmed on appeal, of a securities class action and derivative action alleging the misstatement of company revenues by billions of dollars;
    • in the successful resolution of SEC and DOJ investigations, class action and individual shareholder lawsuits arising from the sale, marketing and voluntary withdrawal of Vioxx. After four years, the SEC closed its investigation into the company’s public disclosures concerning the drug without taking any action. The DOJ investigation, class action and individual shareholder suits favorably settled thereafter; and
    • along with Schering-Plough and certain of the companies’ current or former directors and officers in several securities, derivative, ERISA and opt-out complaints arising out of Merck’s cholesterol-lowering drug Vytorin. Paul, Weiss settled the main action before trial and obtained dismissal of the securities fraud claims asserted in the opt-out cases.
  • Morgan Stanley & Company in the ongoing defense of a consolidated multidistrict litigation alleging that the largest financial institutions were involved in bid-rigging auctions for U.S. Treasury securities. Paul, Weiss was tapped by all 26 defendants, each separately represented by a major law firm, to serve on the defense steering committee.
  • Nicholas S. Schorsch, the founder and former CEO of American Realty Capital Properties (ARCP), in the partial dismissal of a class action and several opt-outs and derivative litigations alleging accounting errors in the company’s public reporting.
  • Oaktree Capital Management in securing the dismissal, affirmed on appeal, of a putative class action and three derivative lawsuits arising out of the merger of Oceanbulk Carriers and Oaktree portfolio company, Star Bulk Carriers. Plaintiff F5 Capital was a minority shareholder in Star Bulk and asserted derivative claims for breach of fiduciary duty, aiding and abetting breach of fiduciary duty and corporate waste, as well as a class action claim for dilution.
  • OnDeck Capital and its directors and officers in the successful defense of a securities class action in which the lead plaintiff voluntarily withdrew after a motion to dismiss was filed.
  • Paramount Pictures Corporation in a major trial victory in an action brought by investors in a special purpose vehicle that in turn invested in a slate of Paramount films. The investors asserted that their investments were induced by a private placement memorandum containing allegedly false and misleading statements. They also asserted claims of federal securities fraud, common law fraud and unjust enrichment. At the close of plaintiffs’ case on liability, the court granted Paramount’s motion to dismiss, holding that plaintiffs had failed to prove liability.
  • Snap, Inc. and several of its directors and executives in the dismissal of a securities class action and ongoing defense of related shareholder derivative actions alleging false and misleading statements about Snap’s preparation for the rollout by Apple of new privacy changes and their impact on prospective advertising revenue.
  • Steven A. Cohen and SAC Capital (now Point72 Asset Management) in criminal and regulatory proceedings and litigations arising out of claims of insider trading. Paul, Weiss negotiated a settlement of an SEC civil enforcement action based on alleged insider trading in Élan and Wyeth, ushered in the resolution of proceedings pertaining to the U.S. Attorney’s criminal indictment of four SAC entities for alleged money laundering, and navigated an SEC administrative proceeding against Cohen seeking to bar him from managing outside investors’ money on the basis that he failed to reasonably supervise certain SAC employees. Most recently, Paul, Weiss defended against putative class actions based on alleged insider trading in the securities of Élan and Wyeth, which resulted in the dismissal of civil RICO claims as well as the settlement of all remaining insider trading cases for 5-10% of potential damages.
  • Teladoc Health, Inc. in the dismissal of a securities class action in New York federal court alleging that Teladoc made materially false and misleading statements concerning the integration process following its merger with Livongo Health.
  • The former CEO and CFO of Triad Guaranty, Inc., a mortgage insurer now in bankruptcy, in securing the dismissal with prejudice of a securities class action alleging that the company and its officers concealed the risks associated with its principal line of business, understated its loss reserves and misreported its risk-to-capital ratio.
  • UBS AG as underwriter of $1.4 billion of certificates of participation issued by special purpose entities to defray municipal pension obligations in all matters arising out of the Detroit bankruptcy.
  • Numerous syndicates of underwriters in Securities Act class actions arising out of public offerings of debt and equity, including, most recently:
    • seventeen financial institutions in the dismissal, on appeal, of all claims related to their role as initial purchasers of $15 billion of senior notes issued in Rule 144A private placements by Valeant Pharmaceuticals;
    • four underwriters led by HSBC and Citigroup in the dismissal, with prejudice, of a securities class action in connection with a stock offering by Horizon Pharma PLC; and
    • sixteen underwriters , including Citi, Goldman Sachs, UBS, J.P. Morgan and Evercore, in a securities class action related to a secondary offering of common stock of an oil drilling company.